ArticleClinical and experimental medicine2025
Identification of circulating immune response-related biomarkers in patients with ANCA-associated glomerulonephritis.
Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the profiles of immune response-related proteins in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN) and identify potential biomarkers for this disease. Plasma was collected from patients with ANCA-GN and healthy controls (HCs). Immune-related proteins were measured using the Immune Response Panel 80-Plex. Differentially expressed proteins (DEPs) were used to differentiate patients with ANCA-GN from HCs via ROC analysis. The prediction performance of the potential biomarkers was assessed using the area under the curve (AUC). Detection results for the immune response-related proteins showed 54 DEPs between ANCA-GN patients and HCs. KEGG enrichment analysis of these 54 DEPs revealed that were mainly enriched in chemokine signaling pathway, IL17 signaling pathway, and JAK-STAT signaling pathway. Among the top 14 core proteins in the protein-protein interaction network, 8 were closely related to renal function, namely IL1A, IFNG, CXCL9, CXCL10, CXCL11, IL4, IL5, and CCL11. The performance of the potential biomarkers for discriminate ANCA-GN was as follows: CCL11, AUC: 0.998; IL4, AUC: 0.950; CXCL9, AUC: 0.917; CXCL10, AUC: 0.887; CXCL11, AUC: 0.807; and IFNG, AUC: 0.821 (all P < 0.001). Distinct immune-related protein profiles were identified in ANCA-GN, and present study revealed that CCL11, IL4, CXCL9, CXCL10, CXCL11, and IFNG could act as potential biomarkers for this disease. In addition, these circulating immune mediators are closely associated with renal function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.